PCRX Pacira BioSciences, Inc. logo

PCRX Pacira BioSciences, Inc.

Healthcare
$23.35-0.55%ClosedMarket Cap: $918.5M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

137.80

PEG

1.29

P/B

1.44

P/S

1.25

EV/EBITDA

10.01

DCF Value

$286.90

FCF Yield

14.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

79.3%

Operating Margin

3.1%

Net Margin

0.7%

ROE

0.7%

ROA

0.4%

ROIC

0.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$177.4M$2.9M$
Q4 null$196.9M$1.6M$
FY null$726.4M$7.0M$
Q3 null$179.5M$5.4M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$29.50

Target (Median)

$29.50

Target Range

$27.00 - $32.00

1 Strong Buy3 Buy2 Hold0 Sell1 Strong Sell
NeedhamBuy
2026-05-01
RBC CapitalSector Perform
2026-05-01
BarclaysEqual Weight
2026-03-26
HC Wainwright & Co.Buy
2026-01-09
NeedhamBuy
2026-01-09

Trading Activity

Insider Trades

View All
Cross Shawnofficer: Chief Financial Officer
SellFri Apr 24
Cross Shawnofficer: Chief Financial Officer
SellFri Apr 24
Cross Shawnofficer: Chief Financial Officer
SellWed Apr 22
Cross Shawnofficer: Chief Financial Officer
SellWed Apr 22
Cross Shawnofficer: Chief Financial Officer
SellWed Apr 22

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

Beta

0.32

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Peers